Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
Benign prostatic hyperplasia is a common disease in men aged over 50 years old, with an incidence increasing to more than 80% over the age of 70, that is increasingly going to attract pharmaceutical interest. Within conventional therapies, such as α-adrenoreceptor antagonists and 5α-reductase inhibi...
Main Authors: | Paolo Governa, Daniela Giachetti, Marco Biagi, Fabrizio Manetti, Luca De Vico |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2016-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/2698.pdf |
Similar Items
-
Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia
by: Daniela Buonocore, et al.
Published: (2018-09-01) -
Fast design of arbitrary length loops in proteins using InteractiveRosetta
by: William F. Hooper, et al.
Published: (2018-09-01) -
In-silico molecular designs to treat neurologic and ophthalmologic diseases caused by sorbitol excess: engineering the Agrobacterium vitis protein
by: Shonit Nair Sharma, et al.
Published: (2023-07-01) -
Entrevista com David Bartram
by: Gustavo Taniguti, et al.
Published: (2020-06-01) -
Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients
by: Tommaso Cai, et al.
Published: (2016-10-01)